A 36-year-old woman complains of recurrent headaches. The pain is located on the right side of the head, is accompanied by nausea, worsens when lifting heavy objects, and typically lasts 2 days. She describes the pain as pulsatile and says that they are usually triggered by eating chocolates. Her headache is not associated with an aura. She sits in a dark room due to her increased discomfort. The patient has tried multiple over-the-counter medications without relief. Which of the following will most likely be the next treatment of choice for acute episodes?
Q212
A 46-year-old woman presents with palpitations, tremors, and anxiety. She says these symptoms have been present ever since a recent change in her diabetic medication. The most recent time she felt these symptoms, her blood glucose level was 65 mg/dL, and she felt better after eating a cookie. Which of the following is the mechanism of action of the drug most likely to have caused this patient's symptoms?
Q213
On the 3rd day post-anteroseptal myocardial infarction (MI), a 55-year-old man who was admitted to the intensive care unit is undergoing an examination by his physician. The patient complains of new-onset precordial pain which radiates to the trapezius ridge. The nurse informs the physician that his temperature was 37.7°C (99.9°F) 2 hours ago. On physical examination, the vital signs are stable, but the physician notes the presence of a triphasic pericardial friction rub on auscultation. A bedside electrocardiogram shows persistent positive T waves in leads V1–V3 and an ST segment: T wave ratio of 0.27 in lead V6. Which of the following is the drug of choice to treat the condition the patient has developed?
Q214
A 45-year-old woman with history of systemic sclerosis presents with new onset dyspnea, which is worsened with moderate exertion. She also complains of chest pain. An ECG was obtained, and showed right-axis deviation. Chest x-ray showed right ventricle hypertrophy. Given the patient's history and presentation, right heart catheterization was performed, which confirmed the suspected diagnosis of pulmonary artery hypertension. It is decided to start the patient on bosentan. Which of the following describes the method of action of bosentan?
Q215
A 47-year-old man with gastroesophageal reflux disease comes to the physician because of severe burning chest pain and belching after meals. He has limited his caffeine intake and has been avoiding food close to bedtime. Esophagogastroduodenoscopy shows erythema and erosions in the distal esophagus. Which of the following is the mechanism of action of the most appropriate drug for this patient?
Q216
A 63-year-old man comes to the physician for a routine health maintenance examination. He feels well. He has a history of hypertension, atrial fibrillation, bipolar disorder, and osteoarthritis of the knees. Current medications include lisinopril, amiodarone, lamotrigine, and acetaminophen. He started amiodarone 6 months ago and switched from lithium to lamotrigine 4 months ago. The patient does not smoke. He drinks 1–4 beers per week. He does not use illicit drugs. Vital signs are within normal limits. Examination shows no abnormalities. Laboratory studies show:
Serum
Na+ 137 mEq/L
K+ 4.2 mEq/L
Cl- 105 mEq/L
HCO3- 24 mEq/L
Urea nitrogen 14 mg/dL
Creatinine 0.9 mg/dL
Alkaline phosphatase 82 U/L
Aspartate aminotransferase (AST) 110 U/L
Alanine aminotransferase (ALT) 115 U/L
Which of the following is the most appropriate next step in management?
Q217
A 45-year-old man has a history of smoking 1 pack per day and drinking a six-pack of beer daily over the last ten years. He is admitted to the medical floor after undergoing a cholecystectomy. One day after the surgery, the patient states that he feels anxious and that his hands are shaking. While being checked for a clean surgical site, the patient starts shaking vigorously and loses consciousness. The patient groans and falls to the floor. His arms and legs begin to jerk rapidly and rhythmically. This episode lasts for almost five minutes, and the patient's airway, breathing, and circulation are stabilized per seizure protocol. What is the best next step for this patient?
Q218
2 hours after being admitted to the hospital because of a fracture of the right ankle, a 75-year-old man continues to complain of pain despite treatment with acetaminophen and ibuprofen. He has a history of dementia and cannot recall his medical history. The presence of which of the following features would most likely be a reason to avoid treatment with morphine in this patient?
Q219
Four days after undergoing a total abdominal hysterectomy for atypical endometrial hyperplasia, a 59 year-old woman reports abdominal bloating and discomfort. She has also had nausea without vomiting. She has no appetite despite not having eaten since the surgery and drinking only sips of water. Her postoperative pain has been well controlled on a hydromorphone patient-controlled analgesia (PCA) pump. Her foley was removed on the second postoperative day and she is now voiding freely. Although she lays supine in bed for most of the day, she is able to walk around the hospital room with a physical therapist. Her temperature is 36.5°C (97.7°F), pulse is 84/min, respirations are 10/min, and blood pressure is 132/92 mm Hg. She is 175 cm (5 ft 9 in) tall and weighs 115 kg (253 lb); BMI is 37.55 kg/m2. Examination shows a mildly distended, tympanic abdomen; bowel sounds are absent. Laboratory studies are within normal limits. An x-ray of the abdomen shows uniform distribution of gas in the small bowel, colon, and rectum without air-fluid levels. Which of the following is the most appropriate next step in the management of this patient?
Q220
A 53-year-old man presents to the office for a routine examination. The medical history is significant for diabetes mellitus, for which he is taking metformin. The medical records show blood pressure readings from three separate visits to fall in the 130–160 mm Hg range for systolic and 90–100 mm Hg range for diastolic. Prazosin is prescribed. Which of the following are effects of this drug?
Autonomic/CV Drugs US Medical PG Practice Questions and MCQs
Question 211: A 36-year-old woman complains of recurrent headaches. The pain is located on the right side of the head, is accompanied by nausea, worsens when lifting heavy objects, and typically lasts 2 days. She describes the pain as pulsatile and says that they are usually triggered by eating chocolates. Her headache is not associated with an aura. She sits in a dark room due to her increased discomfort. The patient has tried multiple over-the-counter medications without relief. Which of the following will most likely be the next treatment of choice for acute episodes?
A. Beta-blocker
B. GABA transaminase inhibitor
C. 5-HT1B/D agonist (Correct Answer)
D. Cyclooxygenase inhibitor
E. D2 receptor blocker
Explanation: ***5-HT1B/D agonist***
- The patient's symptoms (unilateral, pulsatile headache, nausea, photophobia, aggravation by physical activity, chocolate trigger), are highly suggestive of a **migraine**.
- **Triptans (5-HT1B/D agonists)** are the first-line treatment for acute moderate to severe migraine attacks, effectively aborting the headache when over-the-counter medications fail.
*Beta-blocker*
- **Beta-blockers** (e.g., propranolol) are primarily used for **migraine prophylaxis**, meaning they are taken regularly to *prevent* migraines, not to treat acute episodes.
- While they can reduce the frequency and severity of migraines, they are not effective for pain relief once a headache has started.
*GABA transaminase inhibitor*
- A **GABA transaminase inhibitor** (e.g., vigabatrin) is an anti-epileptic drug that increases GABA levels in the brain.
- These are typically used for **epilepsy treatment** and are not a standard treatment for acute migraines.
*Cyclooxygenase inhibitor*
- **Cyclooxygenase inhibitors (NSAIDs)**, such as ibuprofen or naproxen, are often tried for mild to moderate migraines.
- In this case, the patient has already used **multiple over-the-counter medications without relief**, indicating that NSAIDs are likely insufficient for her severe migraine episodes.
*D2 receptor blocker*
- **D2 receptor blockers (antiemetics)** like metoclopramide or prochlorperazine are often used to treat the **nausea and vomiting** associated with migraines.
- While helpful for symptomatic relief, they do not directly treat the headache pain itself and are typically used in conjunction with migraine-specific pain relievers or for intractable nausea.
Question 212: A 46-year-old woman presents with palpitations, tremors, and anxiety. She says these symptoms have been present ever since a recent change in her diabetic medication. The most recent time she felt these symptoms, her blood glucose level was 65 mg/dL, and she felt better after eating a cookie. Which of the following is the mechanism of action of the drug most likely to have caused this patient's symptoms?
A. Inhibition of α-glucosidase
B. Blocking of the ATP-sensitive K+ channels (Correct Answer)
C. Block reabsorption of glucose in proximal convoluted tubule (PCT)
D. Inhibitor of dipeptidyl peptidase (DPP-IV)
E. Decreased hepatic gluconeogenesis
Explanation: ***Blocking of the ATP-sensitive K+ channels***
- The patient's symptoms of palpitations, tremors, anxiety, and a blood glucose level of 65 mg/dL, which improved after eating, are characteristic of **hypoglycemia**.
- **Sulfonylureas**, such as glyburide or glipizide, cause hypoglycemia by **blocking ATP-sensitive K+ channels** on pancreatic beta cells, leading to insulin release independent of blood glucose levels.
*Inhibition of α-glucosidase*
- This mechanism, characteristic of drugs like **acarbose** and **miglitol**, delays carbohydrate absorption in the gut.
- These drugs typically cause **gastrointestinal side effects** such as flatulence and diarrhea, not hypoglycemia or the associated adrenergic symptoms.
*Block reabsorption of glucose in proximal convoluted tubule (PCT)*
- This action describes **SGLT2 inhibitors** (e.g., canagliflozin, empagliflozin), which increase urinary glucose excretion.
- While they can cause **genitourinary infections** and **polyuria**, they have a very low risk of hypoglycemia unless combined with insulin or sulfonylureas.
*Inhibitor of dipeptidyl peptidase (DPP-IV)*
- **DPP-IV inhibitors** (e.g., sitagliptin, saxagliptin) prevent the breakdown of incretins, thus enhancing glucose-dependent insulin secretion and suppressing glucagon.
- These drugs typically have a **low risk of hypoglycemia** because their effects on insulin secretion are glucose-dependent.
*Decreased hepatic gluconeogenesis*
- This is the primary mechanism of **metformin**, which also increases insulin sensitivity in peripheral tissues.
- Metformin is associated with **lactic acidosis** and **gastrointestinal upset**, but it does not typically cause hypoglycemia as a monotherapy because it does not stimulate insulin secretion.
Question 213: On the 3rd day post-anteroseptal myocardial infarction (MI), a 55-year-old man who was admitted to the intensive care unit is undergoing an examination by his physician. The patient complains of new-onset precordial pain which radiates to the trapezius ridge. The nurse informs the physician that his temperature was 37.7°C (99.9°F) 2 hours ago. On physical examination, the vital signs are stable, but the physician notes the presence of a triphasic pericardial friction rub on auscultation. A bedside electrocardiogram shows persistent positive T waves in leads V1–V3 and an ST segment: T wave ratio of 0.27 in lead V6. Which of the following is the drug of choice to treat the condition the patient has developed?
A. Clarithromycin
B. Aspirin (Correct Answer)
C. Furosemide
D. Colchicine
E. Prednisolone
Explanation: **Aspirin**
- The patient's symptoms (new-onset **precordial pain** radiating to the **trapezius ridge**, low-grade fever, and a **triphasic pericardial friction rub** after an **anteroseptal MI**) indicate **post-MI pericarditis** (early pericarditis).
- **Aspirin** is the recommended first-line treatment for post-MI pericarditis, especially in patients who have recently had an MI, due to its anti-inflammatory properties and safety profile in this context.
*Colchicine*
- While **colchicine** is effective for pericarditis, it is typically used as an adjunct to NSAIDs or aspirin, or as a monotherapy for recurrent pericarditis.
- It is not usually the primary drug of choice for acute post-MI pericarditis when aspirin can be used and the patient is stable.
*Prednisolone*
- **Glucocorticoids** like prednisolone should generally be avoided in post-MI pericarditis, as they can impair myocardial healing and potentially lead to ventricular remodeling and rupture.
- They are reserved for refractory cases or when other therapies are contraindicated, and always used with caution due to their side effect profile.
*Clarithromycin*
- **Clarithromycin** is an antibiotic and is indicated for bacterial infections.
- Pericarditis in this context is an inflammatory process, not an infection, so antibiotics would not be effective.
*Furosemide*
- **Furosemide** is a loop diuretic used to reduce fluid overload, often in conditions like heart failure or pulmonary edema.
- It has no role in treating the inflammation associated with pericarditis and would not address the patient's symptoms or underlying condition.
Question 214: A 45-year-old woman with history of systemic sclerosis presents with new onset dyspnea, which is worsened with moderate exertion. She also complains of chest pain. An ECG was obtained, and showed right-axis deviation. Chest x-ray showed right ventricle hypertrophy. Given the patient's history and presentation, right heart catheterization was performed, which confirmed the suspected diagnosis of pulmonary artery hypertension. It is decided to start the patient on bosentan. Which of the following describes the method of action of bosentan?
A. Endothelin receptor antagonist (Correct Answer)
B. Endothelin receptor agonist
C. Anticoagulant
D. Phosphodiesterase type 5 inhibitor
E. Calcium channel blocker
Explanation: ***Endothelin receptor antagonist***
- **Bosentan** is a **dual endothelin receptor antagonist** that blocks both ETA and ETB receptors.
- By blocking these receptors, bosentan prevents the **vasoconstrictive** and **proliferative effects of endothelin-1**, a potent vasoconstrictor implicated in pulmonary hypertension.
*Endothelin receptor agonist*
- An **endothelin receptor agonist** would activate endothelin receptors, leading to **increased vasoconstriction** and worsening pulmonary hypertension.
- This mechanism would **exacerbate** the patient's condition rather than alleviate it.
*Anticoagulant*
- **Anticoagulants** prevent **blood clot formation** and are used in some cases of pulmonary hypertension to reduce the risk of thrombosis.
- However, they do not directly address the primary **vasoconstriction** and **vascular remodeling** found in pulmonary artery hypertension.
*Phosphodiesterase type 5 inhibitor*
- **Phosphodiesterase type 5 (PDE5) inhibitors** like sildenafil and tadalafil increase cyclic GMP levels, leading to **vasodilation** in the pulmonary vasculature.
- While used in pulmonary hypertension, this is a **different mechanism of action** from bosentan.
*Calcium channel blocker*
- **Calcium channel blockers** are used in a small subset of pulmonary hypertension patients who are **vasoreactive** on acute vasodilator testing.
- They primarily act by reducing calcium influx into vascular smooth muscle cells, leading to **vasodilation**, which is not the mechanism of bosentan.
Question 215: A 47-year-old man with gastroesophageal reflux disease comes to the physician because of severe burning chest pain and belching after meals. He has limited his caffeine intake and has been avoiding food close to bedtime. Esophagogastroduodenoscopy shows erythema and erosions in the distal esophagus. Which of the following is the mechanism of action of the most appropriate drug for this patient?
A. Enhancement of the mucosal barrier
B. Inhibition of ATPase (Correct Answer)
C. Inhibition of H2 receptors
D. Neutralization of gastric acid
E. Inhibition of D2 receptors
Explanation: **Inhibition of ATPase**
- The patient's symptoms (severe burning chest pain, belching after meals) and EGD findings (erythema and erosions in the distal esophagus) are classic for **Gastroesophageal Reflux Disease (GERD)**.
- The most effective treatment for GERD involves **proton pump inhibitors (PPIs)**, which work by irreversibly inhibiting the **H+/K+-ATPase** (proton pump) in the gastric parietal cells, thereby reducing acid secretion.
*Enhancement of the mucosal barrier*
- Medications that enhance the mucosal barrier, like **sucralfate**, provide a protective layer and are primarily used for stress ulcers or as an adjunct therapy, not as first-line treatment for erosive esophagitis.
- While beneficial, this mechanism does not directly address the *overproduction of acid* that is the primary cause of reflux and esophageal damage in GERD.
*Inhibition of H2 receptors*
- **H2-receptor blockers** (e.g., ranitidine, cimetidine) reduce acid secretion by blocking histamine's action on parietal cells, but they are generally less potent and effective than PPIs for healing erosive esophagitis.
- They tend to lose effectiveness over time due to **tachyphylaxis** and are often used for milder GERD symptoms or as maintenance therapy.
*Neutralization of gastric acid*
- **Antacids** (e.g., calcium carbonate, aluminum hydroxide) provide rapid, but temporary, relief by directly neutralizing existing stomach acid.
- They do not prevent acid production, making them unsuitable for managing persistent erosive esophagitis.
*Inhibition of D2 receptors*
- This mechanism is characteristic of **dopamine antagonists**, primarily used as antiemetics (e.g., metoclopramide) or antipsychotics (e.g., haloperidol).
- While metoclopramide can increase esophageal sphincter tone and gastric emptying, it is not the primary mechanism of action for the most effective drug in treating erosive esophagitis.
Question 216: A 63-year-old man comes to the physician for a routine health maintenance examination. He feels well. He has a history of hypertension, atrial fibrillation, bipolar disorder, and osteoarthritis of the knees. Current medications include lisinopril, amiodarone, lamotrigine, and acetaminophen. He started amiodarone 6 months ago and switched from lithium to lamotrigine 4 months ago. The patient does not smoke. He drinks 1–4 beers per week. He does not use illicit drugs. Vital signs are within normal limits. Examination shows no abnormalities. Laboratory studies show:
Serum
Na+ 137 mEq/L
K+ 4.2 mEq/L
Cl- 105 mEq/L
HCO3- 24 mEq/L
Urea nitrogen 14 mg/dL
Creatinine 0.9 mg/dL
Alkaline phosphatase 82 U/L
Aspartate aminotransferase (AST) 110 U/L
Alanine aminotransferase (ALT) 115 U/L
Which of the following is the most appropriate next step in management?
A. Discontinue amiodarone (Correct Answer)
B. Discontinue acetaminophen
C. Follow-up laboratory results in 3 months
D. Follow-up laboratory results in 6 months
E. Decrease alcohol consumption
Explanation: ***Discontinue amiodarone***
* The patient has elevated **AST** and **ALT** levels, suggestive of **drug-induced liver injury**. Amiodarone is a known cause of **hepatotoxicity**, which can occur even with normal baseline liver function.
* **Amiodarone-induced liver injury** can range from asymptomatic transaminase elevation to **fulminant hepatic failure**; therefore, discontinuing the drug is crucial to prevent further liver damage.
*Discontinue acetaminophen*
* Although **acetaminophen** can cause **hepatotoxicity** at high doses, the patient is likely taking it at therapeutic doses for osteoarthritis, as suggested by its use in routine care and the absence of overdose symptoms.
* The chronic nature of amiodarone use (6 months) and its well-established risk of **liver injury** make it a more probable cause of the elevated transaminases than **therapeutic-dose acetaminophen**.
*Follow-up laboratory results in 3 months*
* The current **liver enzyme elevations** (AST 110 U/L, ALT 115 U/L) are significant and indicate acute liver injury. Waiting 3 months for follow-up without intervention significantly risks further liver damage.
* Prompt identification and removal of the offending agent are necessary to prevent potentially irreversible **hepatic injury**.
*Follow-up laboratory results in 6 months*
* Delaying follow-up for 6 months is an inappropriate and potentially harmful approach given the current enzyme elevations. There is an immediate need to identify and address the cause of **liver injury**.
* Such a delay could lead to progression of **liver damage**, especially if the causative agent (e.g., amiodarone) continues to be administered.
*Decrease alcohol consumption*
* While excessive alcohol consumption can cause **elevated liver enzymes**, the patient’s intake of 1–4 beers per week is considered light to moderate and is unlikely to be the sole cause of these significant elevations.
* The presence of a known **hepatotoxic medication** (amiodarone) alongside the elevated enzymes makes the drug a much more probable cause than the patient's modest alcohol intake.
Question 217: A 45-year-old man has a history of smoking 1 pack per day and drinking a six-pack of beer daily over the last ten years. He is admitted to the medical floor after undergoing a cholecystectomy. One day after the surgery, the patient states that he feels anxious and that his hands are shaking. While being checked for a clean surgical site, the patient starts shaking vigorously and loses consciousness. The patient groans and falls to the floor. His arms and legs begin to jerk rapidly and rhythmically. This episode lasts for almost five minutes, and the patient's airway, breathing, and circulation are stabilized per seizure protocol. What is the best next step for this patient?
A. Antibiotics
B. Morphine
C. Chest radiograph
D. Urinalysis
E. Lorazepam (Correct Answer)
Explanation: ***Lorazepam***
- The patient exhibits classic signs of **alcohol withdrawal syndrome**, including anxiety, tremors, and a generalized tonic-clonic seizure, which is a medical emergency.
- **Benzodiazepines** like lorazepam are the first-line treatment for alcohol withdrawal seizures due to their ability to potentiate **GABA** (gamma-aminobutyric acid) and stabilize neuronal hyperactivity.
*Antibiotics*
- There is no clinical indication for infection in this patient's presentation; the symptoms are clearly related to **alcohol withdrawal**.
- Administering antibiotics without evidence of infection contributes to **antibiotic resistance** and potential side effects.
*Morphine*
- **Opioids** like morphine can depress the respiratory system and do not address the underlying pathophysiology of alcohol withdrawal seizures.
- Administering morphine could worsen the patient's condition by masking symptoms or increasing the risk of respiratory compromise.
*Chest radiograph*
- A chest radiograph is primarily used to evaluate **pulmonary pathology** like pneumonia or aspiration, which are not the immediate concerns given the seizure and alcohol history.
- While aspiration is a risk during seizures, the immediate priority is to stop the ongoing seizure and address the underlying cause.
*Urinalysis*
- A urinalysis is used to detect urinary tract infections, kidney disease, or metabolic abnormalities, none of which are suggested by the patient's acute presentation of seizures and withdrawal symptoms.
- While it may be part of a broader workup, it is not the most urgent next step for an ongoing or recent seizure due to alcohol withdrawal.
Question 218: 2 hours after being admitted to the hospital because of a fracture of the right ankle, a 75-year-old man continues to complain of pain despite treatment with acetaminophen and ibuprofen. He has a history of dementia and cannot recall his medical history. The presence of which of the following features would most likely be a reason to avoid treatment with morphine in this patient?
A. Severe hypertension
B. Persistent cough
C. Biliary tract dysfunction
D. Tachypnea (Correct Answer)
E. Watery diarrhea
Explanation: ***Tachypnea***
- **Tachypnea** (increased respiratory rate) can indicate underlying **respiratory compromise**, making morphine use risky due to its potential for **respiratory depression**.
- In a 75-year-old with a fracture and possible underlying health issues, exacerbating respiratory distress with opioids could be dangerous.
*Severe hypertension*
- While morphine can cause **hypotension** due to vasodilation, it is not typically contraindicated in severe hypertension.
- In fact, the hypotensive effect of morphine can sometimes be beneficial in conditions like **acute pulmonary edema** associated with hypertension.
*Persistent cough*
- Morphine is known to have **antitussive effects**, meaning it can help suppress a cough.
- Therefore, a persistent cough would more likely be a reason *to use* morphine, rather than avoid it, especially if the cough is non-productive and distressing.
*Biliary tract dysfunction*
- Morphine can cause **spasm of the sphincter of Oddi**, leading to increased pressure in the biliary tract and potentially exacerbating pain in patients with biliary dysfunction.
- However, this is usually a concern for patients with pre-existing biliary colic or pancreatitis, and not a primary contraindication in acute pain management unless other safer alternatives are available.
*Watery diarrhea*
- Opioids like morphine are well-known to cause **constipation** by slowing gut motility, due to their action on mu-opioid receptors in the enteric nervous system.
- Therefore, watery diarrhea would not be a reason to avoid morphine; in some cases, the constipating effect could even be considered beneficial.
Question 219: Four days after undergoing a total abdominal hysterectomy for atypical endometrial hyperplasia, a 59 year-old woman reports abdominal bloating and discomfort. She has also had nausea without vomiting. She has no appetite despite not having eaten since the surgery and drinking only sips of water. Her postoperative pain has been well controlled on a hydromorphone patient-controlled analgesia (PCA) pump. Her foley was removed on the second postoperative day and she is now voiding freely. Although she lays supine in bed for most of the day, she is able to walk around the hospital room with a physical therapist. Her temperature is 36.5°C (97.7°F), pulse is 84/min, respirations are 10/min, and blood pressure is 132/92 mm Hg. She is 175 cm (5 ft 9 in) tall and weighs 115 kg (253 lb); BMI is 37.55 kg/m2. Examination shows a mildly distended, tympanic abdomen; bowel sounds are absent. Laboratory studies are within normal limits. An x-ray of the abdomen shows uniform distribution of gas in the small bowel, colon, and rectum without air-fluid levels. Which of the following is the most appropriate next step in the management of this patient?
A. Esophagogastroduodenoscopy
B. Begin total parenteral nutrition
C. Colonoscopy
D. Gastrografin enema
E. Reduce use of opioid therapy (Correct Answer)
Explanation: ***Reduce use of opioid therapy***
- The patient's symptoms (bloating, discomfort, nausea, absent bowel sounds, diffuse gas on X-ray) after abdominal surgery are consistent with a **postoperative ileus**, which is often exacerbated by **opioid use**.
- Reducing opioids, if pain control allows, can help normalize gastrointestinal motility and resolve the ileus, as her vital signs are stable and there are no signs of obstruction or infection.
*Esophagogastroduodenoscopy*
- This procedure is primarily used to evaluate the **upper gastrointestinal tract** (esophagus, stomach, duodenum) for conditions like ulcers, inflammation, or obstruction.
- While the patient has nausea, there is no evidence suggesting an upper GI pathology that would warrant an EGD, especially with diffuse gas distribution on X-ray.
*Begin total parenteral nutrition*
- **Total parenteral nutrition (TPN)** is indicated when a patient cannot meet their nutritional needs via the enteral route for an extended period, typically more than 7-10 days, or in severe malnutrition.
- The patient has only been NPO for four days post-op, and addressing the underlying cause of her GI symptoms (likely ileus) is the priority before considering long-term nutritional support.
*Colonoscopy*
- **Colonoscopy** is used to visualize the large intestine for conditions such as polyps, cancer, or inflammatory bowel disease.
- There are no symptoms or signs (e.g., lower GI bleeding, chronic diarrhea) to suggest a need for colonoscopy in this acute postoperative setting.
*Gastrografin enema*
- A **Gastrografin enema** is a diagnostic and sometimes therapeutic study used to evaluate the colon and identify conditions like anastomotic leaks or obstructions, particularly in the context of recent surgery.
- The abdominal X-ray shows diffuse gas without air-fluid levels and the patient's symptoms are classic for an ileus, not a mechanical obstruction that would require a contrast study.
Question 220: A 53-year-old man presents to the office for a routine examination. The medical history is significant for diabetes mellitus, for which he is taking metformin. The medical records show blood pressure readings from three separate visits to fall in the 130–160 mm Hg range for systolic and 90–100 mm Hg range for diastolic. Prazosin is prescribed. Which of the following are effects of this drug?
A. Vasodilation, decreased heart rate, bronchial constriction
B. Vasodilation, increased peristalsis, bronchial dilation
C. Vasoconstriction, bladder sphincter constriction, mydriasis
D. Vasoconstriction, increase in AV conduction rate, bronchial dilation
E. Vasodilation, bladder sphincter relaxation (Correct Answer)
Explanation: ***Vasodilation, bladder sphincter relaxation***
- **Prazosin** is an **alpha-1 adrenergic receptor antagonist**, which blocks the effects of norepinephrine on vascular smooth muscle, leading to **vasodilation** and decreased blood pressure.
- Blocking alpha-1 receptors in the bladder neck and prostate causes **bladder sphincter relaxation**, which can improve urine flow and is also useful in benign prostatic hyperplasia (BPH).
- These are the two primary clinically relevant effects of alpha-1 blockade with prazosin.
*Vasodilation, decreased heart rate, bronchial constriction*
- While prazosin causes **vasodilation**, it does not typically decrease heart rate directly; alpha-1 blockade can lead to **reflex tachycardia** due to decreased blood pressure.
- Prazosin has no significant effect on bronchial smooth muscle and does not cause **bronchial constriction**; bronchial effects are primarily mediated by beta-2 receptors or muscarinic (M3) receptors.
*Vasodilation, increased peristalsis, bronchial dilation*
- Prazosin does cause **vasodilation** but does not directly cause **increased peristalsis**; gastrointestinal motility is mainly regulated by the autonomic nervous system via muscarinic receptors and the enteric nervous system.
- Prazosin does not cause **bronchial dilation**; this effect is mediated by beta-2 adrenergic receptor stimulation.
*Vasoconstriction, bladder sphincter constriction, mydriasis*
- Prazosin is an alpha-1 antagonist, meaning it *blocks* **vasoconstriction** and instead causes vasodilation.
- Similarly, it causes **bladder sphincter relaxation**, not constriction.
- Prazosin has minimal effects on pupil size; mydriasis would be caused by alpha-1 agonists or muscarinic antagonists, not alpha-1 antagonists.
*Vasoconstriction, increase in AV conduction rate, bronchial dilation*
- Prazosin causes **vasodilation**, not vasoconstriction.
- It does not significantly affect **AV conduction rate** or directly cause **bronchial dilation**.